Jeanie Tryggestad MD (Speaker)

Dr. Jeanie B. Tryggestad is an associate professor of pediatrics in the section of diabetes/endocrinology at the University of Oklahoma Health Sciences Center and holds the Paul and Ruth Jonas Chair in Diabetes/Endocrinology. She received her Bachelor of Science in Biology from Oklahoma Christian University. She completed her medical school education at the University of Oklahoma Health Sciences Center graduating with distinction. Dr. Tryggestad completed her residency in pediatrics and fellowship in pediatric endocrinology at the University of Oklahoma Health Sciences Center as well. She is board certified in pediatrics as well as pediatric endocrinology. Dr. Tryggestad’s clinical research interests are on the impact of youth onset type 2 diabetes on complications. She is the Oklahoma site PI for the NIH-funded DISCOVERY of predictors of type 2 diabetes in youth study. She was a Co-Principle Investigator for the NIH-funded TODAY trial in Oklahoma and served on the Comorbidity Assessment Committee. She is also the MPI for the Oklahoma Pediatric Clinical Trials Network. Dr. Tryggestad’s other research interest focus on the impact of maternal diabetes on the future cardiometabolic health of the offspring and the impact of obesity and diabetes on vascular function. She has been funded through NIH to understand the impact of maternal diabetes on miRNA expression and protein regulation in infants. Dr. serves as the co-director of the type 2 diabetes comprehensive clinic in youth at OU Children’s in Oklahoma City. Her clinical interests are focused on type 1 and type 2 diabetes with a special focus on Native American populations.